Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp has demonstrated resilience in its domestic screen base, which has experienced slight growth post-pandemic, contrasting with the overall industry decline. The company is poised for consistent revenue growth, with projected total revenues for 2026 increasing approximately 9% to $437 million, driven by a mix of local language and global fare, alongside an uptick in filmed-for-IMAX titles. Furthermore, Imax aims to enhance revenue through a broader offering of alternative content, supported by an expanding global footprint and increased marketing efforts to drive attendance.

Bears say

The recent excerpts indicate a troubling outlook for Imax Corp, primarily due to the changing dynamics in the exhibition industry and pressures on box office revenues. The company's shift to a premium model has reduced the required total box office for an IMAX zone to about $7 million, significantly lower than the previous threshold of $20 million, suggesting challenges in driving ticket sales. Additionally, the continued decline in shares of theater exhibitors prompts concerns about audience demand and the risk of underperforming films, which could hinder overall box office growth and, consequently, Imax's financial performance.

IMAX (IMAX) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 9 analysts, IMAX (IMAX) has a Buy consensus rating as of Feb 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.